StockData
DBV Technologies S.A. logo

DBV Technologies S.A. (DBVT) stock

DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 6/30
$11.43−0.45 (-3.79%)

Close on Nov 12, 2026Market cap $718.69MP/E –Yield –

DBV Technologies profit margin

Profit margin (net margin) is net income as a percentage of revenue.

DBV Technologies's profit margin for the twelve months ending Sep 30, 2026 was -5405.3%. For fiscal 2025 it was -2607.3%, against -2744.4% the year before. The highest annual figure on record is 1987.5% in fiscal 2022.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-2607.3%+137.1
FY2024Dec 31, 2024-2744.4%−3206.6
FY2023Dec 31, 2023462.3%−1525.2
FY2022Dec 31, 20221987.5%+3701.0
FY2021Dec 31, 2021-1713.5%−298.5
FY2020Dec 31, 2020-1415.0%−245.5
FY2019Dec 31, 2019-1169.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-4031.3%−2845.5
Q2 FY2026Jun 30, 2026-7200.0%−4406.7
Q1 FY2026Mar 31, 2026-5288.9%−1901.4
Q4 FY2025Dec 31, 2025-7051.4%−2547.5
Q3 FY2025Sep 30, 2025-1185.7%+1654.0
Q2 FY2025Jun 30, 2025-2793.3%+59.0
Q1 FY2025Mar 31, 2025-3387.5%−1444.0
Q4 FY2024Dec 31, 2024-4503.9%−6016.6
Q3 FY2024Sep 30, 2024-2839.7%−2134.2
Q2 FY2024Jun 30, 2024-2852.4%−1792.8
Q1 FY2024Mar 31, 2024-1943.5%−1006.4
Q4 FY2023Dec 31, 20231512.7%+2346.2
Q3 FY2023Sep 30, 2023-705.6%+801.2
Q2 FY2023Jun 30, 2023-1059.6%−403.4
Q1 FY2023Mar 31, 2023-937.1%−470.8
Q3 FY2022Sep 30, 2022-833.5%+983.0
Q2 FY2022Jun 30, 2022-1506.8%−505.5
Q1 FY2022Mar 31, 2022-656.2%+88.3
Q4 FY2021Dec 31, 2021-466.3%+868.9
Q3 FY2021Sep 30, 2021-1816.6%−949.8
Q1 FY2021Mar 31, 2021-1001.3%–
Q3 FY2020Sep 30, 2020-744.5%–
Q2 FY2020Jun 30, 2020-1335.3%–
Q1 FY2020Mar 31, 2020-866.8%–

More DBV Technologies figures

See a number that looks wrong?